• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RIP1 和 RIP3 通过增加细胞内过氧化氢促进紫草素诱导的胶质瘤细胞糖酵解抑制。

RIP1 and RIP3 contribute to shikonin-induced glycolysis suppression in glioma cells via increase of intracellular hydrogen peroxide.

机构信息

Department of Neurosurgery, First Hospital of Jilin University, Changchun, 130021, China; Research Center of Neuroscience, First Hospital of Jilin University, Changchun, 130021, China.

Department of Anesthesiology, First Hospital of Jilin University, Changchun, 130021, China.

出版信息

Cancer Lett. 2018 Jul 1;425:31-42. doi: 10.1016/j.canlet.2018.03.046. Epub 2018 Mar 30.

DOI:10.1016/j.canlet.2018.03.046
PMID:29608987
Abstract

RIP1 and RIP3 are necroptosis initiators, but their roles in regulation of glycolysis remain elusive. In this study, we found shikonin activated RIP1 and RIP3 in glioma cells in vitro and in vivo, which was accompanied with glycolysis suppression. Further investigation revealed that shikonin-induced decreases of glucose-6-phosphate and pyruvate and downregulation of HK II and PKM2 were significantly prevented when RIP1 or RIP3 was pharmacologically inhibited or genetically knocked down with SiRNA. Moreover, shikonin also triggered accumulation of intracellular HO and depletion of GSH and cysteine. Mitigation of intracellular HO via supplement of GSH reversed shikonin-induced glycolysis suppression. The role of intracellular HO in regulation of glycolysis suppression was further confirmed in the cells treated with exogenous HO. Notably, inhibition of RIP1 or RIP3 prevented intracellular HO accumulation, which was correlated with preventing shikonin-induced downregulation of x-CT and depletion of GSH and cysteine. In addition, supplement of pyruvate effectively inhibited shikonin- or exogenous HO-induced accumulation of intracellular HO and glioma cell death. Taken together, we demonstrated in this study that RIP1 and RIP3 contributed to shikonin-induced glycolysis suppression via increasing intracellular HO.

摘要

RIP1 和 RIP3 是细胞坏死的启动子,但它们在糖酵解调控中的作用仍不清楚。在本研究中,我们发现紫草素在体外和体内激活了胶质瘤细胞中的 RIP1 和 RIP3,同时伴随着糖酵解的抑制。进一步的研究表明,当用药理学抑制剂或 siRNA 基因敲低 RIP1 或 RIP3 时,紫草素诱导的葡萄糖-6-磷酸和丙酮酸减少以及 HK II 和 PKM2 下调明显受到阻止。此外,紫草素还触发了细胞内 HO 的积累和 GSH 和半胱氨酸的耗竭。通过补充 GSH 来减轻细胞内 HO 可逆转紫草素诱导的糖酵解抑制。在用外源性 HO 处理的细胞中进一步证实了细胞内 HO 在调节糖酵解抑制中的作用。值得注意的是,抑制 RIP1 或 RIP3 可防止细胞内 HO 的积累,这与阻止紫草素诱导的 x-CT 下调以及 GSH 和半胱氨酸耗竭有关。此外,补充丙酮酸可有效抑制紫草素或外源性 HO 诱导的细胞内 HO 积累和胶质瘤细胞死亡。综上所述,本研究表明,RIP1 和 RIP3 通过增加细胞内 HO 促进了紫草素诱导的糖酵解抑制。

相似文献

1
RIP1 and RIP3 contribute to shikonin-induced glycolysis suppression in glioma cells via increase of intracellular hydrogen peroxide.RIP1 和 RIP3 通过增加细胞内过氧化氢促进紫草素诱导的胶质瘤细胞糖酵解抑制。
Cancer Lett. 2018 Jul 1;425:31-42. doi: 10.1016/j.canlet.2018.03.046. Epub 2018 Mar 30.
2
RIP1 and RIP3 contribute to shikonin-induced DNA double-strand breaks in glioma cells via increase of intracellular reactive oxygen species.RIP1 和 RIP3 通过增加细胞内活性氧诱导神经胶质瘤细胞中紫草素诱导的 DNA 双链断裂。
Cancer Lett. 2017 Apr 1;390:77-90. doi: 10.1016/j.canlet.2017.01.004. Epub 2017 Jan 17.
3
Shikonin induces glioma cell necroptosis in vitro by ROS overproduction and promoting RIP1/RIP3 necrosome formation.紫草素通过过量产生活性氧和促进RIP1/RIP3坏死小体形成在体外诱导胶质瘤细胞坏死性凋亡。
Acta Pharmacol Sin. 2017 Nov;38(11):1543-1553. doi: 10.1038/aps.2017.112. Epub 2017 Aug 17.
4
MLKL contributes to shikonin-induced glioma cell necroptosis via promotion of chromatinolysis.MLKL 通过促进染色质溶解促进紫草素诱导的神经胶质瘤细胞坏死性凋亡。
Cancer Lett. 2019 Dec 28;467:58-71. doi: 10.1016/j.canlet.2019.09.007. Epub 2019 Sep 24.
5
The anti-tumor effect of shikonin on osteosarcoma by inducing RIP1 and RIP3 dependent necroptosis.紫草素通过诱导 RIP1 和 RIP3 依赖性坏死性细胞凋亡对骨肉瘤的抗肿瘤作用。
BMC Cancer. 2013 Dec 6;13:580. doi: 10.1186/1471-2407-13-580.
6
Emodin induced necroptosis in the glioma cell line U251 via the TNF-α/RIP1/RIP3 pathway.大黄素通过 TNF-α/RIP1/RIP3 通路诱导脑胶质瘤 U251 细胞发生坏死性凋亡。
Invest New Drugs. 2020 Feb;38(1):50-59. doi: 10.1007/s10637-019-00764-w. Epub 2019 Mar 28.
7
Cytosolic calcium mediates RIP1/RIP3 complex-dependent necroptosis through JNK activation and mitochondrial ROS production in human colon cancer cells.胞质钙通过激活JNK和产生活线粒体ROS介导人结肠癌细胞中RIP1/RIP3复合物依赖性坏死性凋亡。
Free Radic Biol Med. 2017 Jul;108:433-444. doi: 10.1016/j.freeradbiomed.2017.04.010. Epub 2017 Apr 14.
8
Synthesis and biological evaluation of celastrol derivatives as potential anti-glioma agents by activating RIP1/RIP3/MLKL pathway to induce necroptosis.通过激活 RIP1/RIP3/MLKL 通路诱导坏死性细胞死亡来合成和评估塞拉菌素衍生物作为潜在的抗神经胶质瘤药物。
Eur J Med Chem. 2022 Feb 5;229:114070. doi: 10.1016/j.ejmech.2021.114070. Epub 2021 Dec 23.
9
Cyclophilin A contributes to shikonin-induced glioma cell necroptosis and promotion of chromatinolysis.亲环蛋白 A 促进紫草素诱导的神经胶质瘤细胞坏死性凋亡和染色质溶解。
Sci Rep. 2022 Aug 29;12(1):14675. doi: 10.1038/s41598-022-19066-y.
10
RIP1/RIP3-regulated necroptosis as a target for multifaceted disease therapy (Review).RIP1/RIP3 调节的坏死性凋亡作为多方面疾病治疗的靶点(综述)。
Int J Mol Med. 2019 Sep;44(3):771-786. doi: 10.3892/ijmm.2019.4244. Epub 2019 Jun 14.

引用本文的文献

1
Shikonin inhibits epithelial-mesenchymal transition in glioblastoma cells by upregulating p53 and promoting miR-361-5p level to suppress ZEB1 expression.紫草素通过上调p53和提高miR-361-5p水平以抑制锌指蛋白E盒结合因子1(ZEB1)的表达,从而抑制胶质母细胞瘤细胞的上皮-间质转化。
BMC Neurosci. 2025 Jul 1;26(1):37. doi: 10.1186/s12868-025-00956-6.
2
Targeting PPARα activation sensitizes glioblastoma cells to temozolomide and reverses acquired resistance by inhibiting H3K18 lactylation.靶向激活过氧化物酶体增殖物激活受体α(PPARα)可使胶质母细胞瘤细胞对替莫唑胺敏感,并通过抑制组蛋白H3第18位赖氨酸乳酸化(H3K18 lactylation)逆转获得性耐药。
Acta Pharmacol Sin. 2025 Jun 11. doi: 10.1038/s41401-025-01600-z.
3
Prognostic Role of Pyruvate Kinase M2 in High-Grade Gliomas: A Quantitative Immunohistochemistry Study.
丙酮酸激酶M2在高级别胶质瘤中的预后作用:一项定量免疫组织化学研究
Cureus. 2025 Jan 26;17(1):e78035. doi: 10.7759/cureus.78035. eCollection 2025 Jan.
4
Shikonin suppresses proliferation of osteosarcoma cells by inducing ferroptosis through promoting Nrf2 ubiquitination and inhibiting the xCT/GPX4 regulatory axis.紫草素通过促进Nrf2泛素化和抑制xCT/GPX4调节轴诱导铁死亡,从而抑制骨肉瘤细胞的增殖。
Front Pharmacol. 2024 Dec 5;15:1490759. doi: 10.3389/fphar.2024.1490759. eCollection 2024.
5
Shikonin Induces Glioma Necroptosis, Stemness Decline, and Impedes (Immuno)Proteasome Activity.紫草素诱导胶质瘤坏死性凋亡、干性下降,并抑制(免疫)蛋白酶体活性。
Stem Cells Int. 2024 Mar 14;2024:1348269. doi: 10.1155/2024/1348269. eCollection 2024.
6
Targeting dysregulated intracellular immunometabolism within synovial microenvironment in rheumatoid arthritis with natural products.利用天然产物靶向类风湿关节炎滑膜微环境中失调的细胞内免疫代谢。
Front Pharmacol. 2024 Jul 22;15:1403823. doi: 10.3389/fphar.2024.1403823. eCollection 2024.
7
Pharmacological Significance of with Special Insights into Shikonin and Its Potential in the Food Industry.的药理意义,特别深入探讨紫草素及其在食品工业中的潜力。
Foods. 2024 Apr 27;13(9):1350. doi: 10.3390/foods13091350.
8
Glycolysis: an emerging regulator of osteoarthritis.糖酵解:骨关节炎的一个新调控因子。
Front Immunol. 2024 Jan 9;14:1327852. doi: 10.3389/fimmu.2023.1327852. eCollection 2023.
9
Recent advances in natural compounds inducing non-apoptotic cell death for anticancer drug resistance.天然化合物诱导非凋亡性细胞死亡以克服抗癌药物耐药性的最新进展
Cancer Drug Resist. 2023 Oct 19;6(4):729-747. doi: 10.20517/cdr.2023.78. eCollection 2023.
10
Shikonin induces ferroptosis in multiple myeloma GOT1-mediated ferritinophagy.紫草素通过GOT1介导的铁蛋白自噬诱导多发性骨髓瘤细胞发生铁死亡。
Front Oncol. 2022 Oct 25;12:1025067. doi: 10.3389/fonc.2022.1025067. eCollection 2022.